Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Sarcoma Patients Treated With Immunotherapy at Memorial Sloan Kettering Cancer Center

NCT06113315 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT06113315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06113315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Sarcoma Patients Treated With Immunotherapy at Memorial Sloan Kettering Cancer Center
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 27, 2023
Completion date
October 31, 2028
Enrollment
250 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma